Literature DB >> 3018541

Expression of human beta-globin genes in transgenic mice: effects of a flanking metallothionein-human growth hormone fusion gene.

T M Townes, H Y Chen, J B Lingrel, R D Palmiter, R L Brinster.   

Abstract

In an attempt to place a human beta-globin gene in an open chromatin domain regardless of its site of integration in the mouse genome, we microinjected into fertilized mouse eggs a construct in which the human beta-globin gene and a mouse metallothionein-human growth hormone fusion gene were juxtaposed and oriented in opposite directions. Mice that developed from injected eggs and that grew larger than normal were analyzed for human beta-globin mRNA. The globin genes were not expressed in erythroid tissue but were expressed with the same tissue specificity as metallothionein-human growth hormone. These results suggest that sequences which control metallothionein-human growth hormone gene expression are capable of stimulating the expression of a flanking gene in an orientation-independent and tissue-specific manner. As a control for this experiment, we deleted the metallothionein-human growth hormone transcription unit and noted that the human beta-globin gene then was expressed at high levels with erythroid tissue specificity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3018541      PMCID: PMC366915          DOI: 10.1128/mcb.5.8.1977-1983.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  22 in total

1.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

2.  The nucleotide sequence of the human beta-globin gene.

Authors:  R M Lawn; A Efstratiadis; C O'Connell; T Maniatis
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

3.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

Authors:  S D Gillies; S L Morrison; V T Oi; S Tonegawa
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

4.  Immunoglobulin gene transcription is activated by downstream sequence elements.

Authors:  C Queen; D Baltimore
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes.

Authors:  J Banerji; L Olson; W Schaffner
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

6.  Introduction of a rabbit beta-globin gene into the mouse germ line.

Authors:  F Costantini; E Lacy
Journal:  Nature       Date:  1981-11-05       Impact factor: 49.962

7.  Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNAase I.

Authors:  J Stalder; A Larsen; J D Engel; M Dolan; M Groudine; H Weintraub
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

8.  Microinjection of a rabbit beta-globin gene into zygotes and its subsequent expression in adult mice and their offspring.

Authors:  T E Wagner; P C Hoppe; J D Jollick; D R Scholl; R L Hodinka; J B Gault
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Specific expression of a foreign beta-globin gene in erythroid cells of transgenic mice.

Authors:  K Chada; J Magram; K Raphael; G Radice; E Lacy; F Costantini
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

10.  The human beta-globin gene and a functional viral thymidine kinase gene in developing mice.

Authors:  E F Wagner; T A Stewart; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

View more
  11 in total

Review 1.  Transgenic regulation in laboratory animals.

Authors:  S Rusconi
Journal:  Experientia       Date:  1991-09-15

2.  High-level erythroid expression of human alpha-globin genes in transgenic mice.

Authors:  T M Ryan; R R Behringer; T M Townes; R D Palmiter; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 3.  Germ-line transformation of mice.

Authors:  R D Palmiter; R L Brinster
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

4.  The human beta-globin locus activation region alters the developmental fate of a human fetal globin gene in transgenic mice.

Authors:  T Enver; A J Ebens; W C Forrester; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Strategies for selection marker-free swine transgenesis using the Sleeping Beauty transposon system.

Authors:  Daniel F Carlson; John R Garbe; Wenfang Tan; Mike J Martin; John R Dobrinsky; Perry B Hackett; Karl J Clark; Scott C Fahrenkrug
Journal:  Transgenic Res       Date:  2011-01-09       Impact factor: 2.788

6.  The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in transgenic mice.

Authors:  Y W Choi; D Henrard; I Lee; S R Ross
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

7.  Two 3' sequences direct adult erythroid-specific expression of human beta-globin genes in transgenic mice.

Authors:  R R Behringer; R E Hammer; R L Brinster; R D Palmiter; T M Townes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Differential expression of mouse beta/goat beta c, mouse beta/goat beta F, and mouse beta/goat epsilon II hybrid globin genes in murine erythroleukemia cells.

Authors:  C B Kerlakian; S W Toth; E D Kuempel; D S Luse
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

9.  Studies on the expression of an H-2K/human growth hormone fusion gene in giant transgenic mice.

Authors:  D Morello; G Moore; A M Salmon; M Yaniv; C Babinet
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

10.  Enzymatic engineering of the porcine genome with transposons and recombinases.

Authors:  Karl J Clark; Daniel F Carlson; Linda K Foster; Byung-Whi Kong; Douglas N Foster; Scott C Fahrenkrug
Journal:  BMC Biotechnol       Date:  2007-07-17       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.